Dorsal Scapular Nerve Injection Combined With Muscle Needle Release

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ultrasound-guided perineural injection (PIT) of 5% dextrose (D5W) hydrodissection has been widely used in the treatment of peripheral entrapment neuropathies. However, there are few studies investigating the efficacy of PIT using D5W HD for dorsal scapular nerve (DSN) entrapment. Generally, the DSN entrapment causes the stiffness of the major and minor rhomboideus(2). In clinical practice, the investigators observed that ultrasound-guided PIT using D5W HD combined with needle release of major and minor rhomboideus significantly relieved the pain of scapular region. Therefore, the investigators aimed to evaluate the 6-month efficacy of this procedure for the participants with DSN entrapment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

NCT06251882

Meralgia Paresthetica

COMPLETED NA

Effect of Different Ultrasound Doses on Median Nerve Conduction Parameters

NCT05233488

Entrapment Neuropathies

UNKNOWN NA

Neuromuscular Ultrasound in Correlation to Neurophysiological Findings

NCT04092140

Carpal Tunnel Syndrome Diabetic Neuropathies Guillain-Barre Syndrome

UNKNOWN

Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy

NCT04699734

Painful Diabetic Neuropathy Neuropathic Pain Neuropathy;Peripheral

RECRUITING NA

Can Ultrasound Detect Diabetic Peripheral Neuropathy?

NCT01261442

Distal Symmetric Polyneuropathy (DSPN)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dorsal Scapular Nerve Entrapment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Ultrasound-guided dorsal scapular nerve injection combined with needle release of major and minor rhomboideus

Group Type EXPERIMENTAL

Ultrasound-guided injection combined with needle release

Intervention Type OTHER

Ultrasound-guided PIT using D5W HD for dorsal scapular nerve combined with needle release of major and minor rhomboideus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound-guided injection combined with needle release

Ultrasound-guided PIT using D5W HD for dorsal scapular nerve combined with needle release of major and minor rhomboideus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with DSN entrapment confirmed by electrophysiological study;
* age 18-80 years;
* patients who were irresponsive to conservative treatment;
* symptoms persisted for more than 3 months.

Exclusion Criteria

* pregnancy
* DSN entrapment caused by trauma, surgery or occupying lesions of DSN;
* concurrent presence of rheumatic immune diseases, hypothyroidism, or diabetes mellitus;
* C5/6 lumbar radiculopathy;
* previous history of local injection or surgery for DSN entrapment.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No